Not Enough Evidence To Support Routine Prostate Cancer Screening

There is insufficient evidence to support population-wide screening for prostate using the prostate specific antigen (PSA) test, conclude two papers published on bmj.com today. The authors say that the PSA test cannot distinguish between lethal and harmless prostate , leading to overdiagnosis and overtreatment of healthy men.


Read more

Related posts

Leave a Reply